PRINCIPAL FINANCIAL GROUP INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$494,270
-90.1%
12,885
-84.8%
0.00%
-100.0%
Q1 2024$4,973,022
+248.1%
84,604
+254.5%
0.00%
+200.0%
Q4 2023$1,428,440
+39.2%
23,863
-11.6%
0.00%0.0%
Q3 2023$1,026,434
-77.9%
26,983
-47.0%
0.00%
-66.7%
Q2 2023$4,642,091
+175.6%
50,956
+99.5%
0.00%
+200.0%
Q1 2023$1,684,619
-55.4%
25,540
-65.0%
0.00%
-66.7%
Q4 2022$3,773,900
+120.6%
72,982
+191.4%
0.00%
+200.0%
Q3 2022$1,711,000
+49.8%
25,046
-0.8%
0.00%0.0%
Q2 2022$1,142,000
-7.5%
25,250
+3.9%
0.00%0.0%
Q1 2022$1,235,000
+15.5%
24,304
+7.5%
0.00%0.0%
Q4 2021$1,069,000
+8.4%
22,608
-24.4%
0.00%0.0%
Q3 2021$986,000
-46.1%
29,909
+3.4%
0.00%0.0%
Q2 2021$1,828,000
+43.8%
28,937
-2.3%
0.00%0.0%
Q1 2021$1,271,000
-27.9%
29,609
-3.9%
0.00%0.0%
Q4 2020$1,763,000
+133.8%
30,824
+23.3%
0.00%0.0%
Q3 2020$754,000
-11.7%
24,992
-4.4%
0.00%0.0%
Q2 2020$854,000
+231.0%
26,144
+171.9%
0.00%
Q1 2020$258,000
-9.5%
9,616
+3.4%
0.00%
Q4 2019$285,000
+35.1%
9,298
+6.1%
0.00%
Q3 2019$211,000
-3.7%
8,767
+1.4%
0.00%
Q2 2019$219,0008,6470.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders